Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01305525 · ClinicalTrials.gov registry record

A Prospective Clinical Outcomes Registry

A clinical trial of Pain, sponsored by Abbott Medical Devices.

Completed
Registry status
614
Enrollment target
20
Study locations

NCT01305525: Completed study of Pain, sponsored by Abbott Medical Devices.

NCT01305525 is a study of Pain that has completed, run by Abbott Medical Devices. The registered enrollment target is 614 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (103% higher). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01305525, a study of Pain, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
614 participants
Enrollment target
20
Study locations

Study Summary

This is a prospective non-interventional 24 month post implant registry. Any patient that receives a St. Jude Medical FDA approved implantable neuromodulation system is eligible for enrollment. A minimum of 600 patients will be enrolled from a minimum of 30 sites. Patients will be enrolled post-implant and followed for 24 months. Data are collected at enrollment (within 30 days of device implant), and routine care follow-up visits at 3 months, 6 months, 12 months, 18 months and 24 months.

Primary Outcome

The primary objective of the registry is to create a prospective, outcome registry of patients implanted with neuromodulation devices.

Conditions Studied

Pain

Interventions

  • DEVICE St. Jude Medical Spinal Cord Stimulation Systems

Study Locations (20)

New York

  • - New York
  • - Syracuse
  • - Utica
  • - Williamsville

California

  • - Azusa
  • - Chula Vista
  • - Sacramento

Florida

  • - Jacksonville
  • - Tampa

Indiana

  • - Evansville
  • - Muncie

Michigan

  • - Bloomfield Hills
  • - Waterford

North Carolina

  • - Durham
  • - Winston-Salem

Arizona

  • - Scottsdale

Kentucky

  • - Louisville

Trial Details

FieldValue
Enrollment Target 614 participants
Start Date 2009-06
Est. Completion 2014-04
Abbott Medical Devices

261 total trials

What the finished NCT01305525 record still lists

NCT01305525 is an observational study that tracks outcomes without assigning an intervention. The registered 614 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (103% higher).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which St. Jude Medical Spinal Cord Stimulation Systems is the first listed.

NCT01305525 names 20 study sites across 11 states, led by New York, California, Florida.

Frequently Asked Questions

What is clinical trial NCT01305525 about?

NCT01305525 is a clinical study titled "A Prospective Clinical Outcomes Registry". This is a prospective non-interventional 24 month post implant registry. Any patient that receives a St. Jude Medical FDA approved implantable neuromodulation system is eligible for enrollment. A minimum of 600 patients will be enrolled from a minimum of 30 sites. Patients will be enrolled post-imp...

What is the current status of trial NCT01305525?

This trial is currently completed. The enrollment target is 614 participants. The study started on 2009-06. Estimated completion is 2014-04.

What conditions does trial NCT01305525 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01305525?

The interventions under investigation include: St. Jude Medical Spinal Cord Stimulation Systems (DEVICE).

Who is sponsoring clinical trial NCT01305525?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01305525 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01305525's enrollment target sits among peer trials

614 23rd of 374 higher than 352 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03821857 · 614 participants · Phase 4

    Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease

  • NCT05006716 · 614 participants · Phase 1

    A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

  • NCT06170788 · 614 participants · Phase 3

    Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  • NCT07409272 · 614 participants · Phase 3

    A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01305525, the US trial registry maintained by the National Library of Medicine. NCT01305525 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.